Peroxisome proliferator activated receptor ligands affect progesterone and 17β-estradiol secretion by porcine corpus luteum during early pregnancy

Journal of Physiology and Pharmacology

Volumn 65, Issue 5, 2014, Pages 709-717

  Kurzynska, A ^a   Bogacki, M ^b   Chojnowska, K ^a   Bogacka, Iwona ^a  

^a UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^b INSTITUTE OF ANIMAL REPRODUCTION AND FOOD RESEARCH   (Poland)

Author keywords

15d prostaglandin J2; 17 estradiol; Corpus luteum; Estrous cycle; Implantation; Peroxisome proliferator activated receptor; Pregnancy; Progesterone

Indexed keywords

3 (OR 17) BETA HYDROXYSTEROID DEHYDROGENASE; ESTRADIOL; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROGESTERONE; PROSTAGLANDIN J2; ROSIGLITAZONE; UNCLASSIFIED DRUG; 2 CHLORO 5 NITRO N (4 PYRIDYL)BENZAMIDE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 2-CHLORO-5-NITROBENZANILIDE; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; 4-(3-(2-PROPYL-3-HYDROXY-4-ACETYL)PHENOXY)PROPYLOXYPHENOXY ACETIC ACID; 9-DEOXY-DELTA-9-PROSTAGLANDIN D2; ANILIDE; BENZAMIDE DERIVATIVE; INDOLE DERIVATIVE; LIGAND; PHENOXYACETIC ACID DERIVATIVE; PIRINIXIC ACID; PROSTAGLANDIN D2; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CORPUS LUTEUM FUNCTION; ESTRUS CYCLE; FEMALE; FIRST TRIMESTER PREGNANCY; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SEQUENCE ANALYSIS; TREATMENT OUTCOME; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CORPUS LUTEUM; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; PIG; PREGNANCY; SECRETION (PROCESS);

3-HYDROXYSTEROID DEHYDROGENASES; ANILIDES; ANIMALS; BENZAMIDES; CORPUS LUTEUM; ESTRADIOL; ESTROUS CYCLE; FEMALE; GENE EXPRESSION; INDOLES; LIGANDS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHENOXYACETATES; PREGNANCY; PROGESTERONE; PROSTAGLANDIN D2; PYRIDINES; PYRIMIDINES; RNA, MESSENGER; SWINE; THIAZOLIDINEDIONES;

EID: 84908462664     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Mueller E, Sarraf, P, Tontonoz P, et al. Terminal differentiation of human breast cancer through PPARg. Mol Cell 1998; 1: 465-470
2. Lazennec G, Canaple L, Saugy D, Whali W. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol Endocrinol 2000; 14: 1962-1975
3. Lambe KG, Tugwood JD. A human peroxisome-proliferatoractivated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs. Eur J Biochem 1996; 239: 1-7
4. Kota BP, Huang TH, Roufogalis BD. An overview on biological mechanisms of PPARs. Pharmacol Res 2005; 51: 85-94
5. Krey G, Braissant O, L'Horset F, et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 1997; 11: 779-791
6. Bogacka I, Xie H, Bray GA, Smith SR. The effect of pioglitazone on peroxisome proliferator-activated receptorgamma target genes related to lipid storage in vivo. Diabetes Care 2004; 27: 1660-1667
7. Bogacka I, Gettys TW, De Jonge L, et al. The effect of betaadrenergic and peroxisome proliferator-activated receptorgamma stimulation on target genes related to lipid metabolism in human subcutaneous adipose tissue. Diabetes Care 2007; 30: 1179-1186
8. Wierzbicki M, Chabowski A, Zendzian-Piotrowska M, Gorski J. Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver. J Physiol Pharmacol 2009; 60: 99-106
9. Krskova K, Filipcik P, Zilka N, et al. Angiotensinogen and angiotensin-converting enzyme mRNA decrease and AT1 receptor mRNAand protein increase in epididymal fat tissue accompany age-induced elevation of adiposity and reductions in expression of GLUT4 and peroxisome proliferator-activated receptor (PPARg). J Physiol Pharmacol 2011; 62: 403-410
10. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999; 20: 649-688
11. Komar CM, Braissant O, Wahli W, Curry TE Jr. Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period. Endocrinology 2001; 142: 4831-4838
12. Miana M, de Las Heras N, Rodriguez C, et al. Effect of eplerenone on hypertension-associated renal damage in rats: potential role of peroxisome proliferator activated receptor gamma (PPAR-g). J Physiol Pharmacol 2011; 62: 87-94
13. Lim H, Gupta RA, Ma WG, et al. Cyclo-oxygenase-2- derived prostacyclin mediates embryo implantation in the mouse via PPARd. Genes Dev 1999; 13: 1561-1574
14. Komar CM. Peroxisome proliferator-activated receptors (PPARs) and ovarian function-implications for regulating steroidogenesis, differentiation, and tissue remodeling. Reprod Biol Endocrinol 2005; 3: 41
15. Yang J, Chen L, Zhang X, et al. PPARs and female reproduction: evidence from genetically manipulated mice. PPAR Res 2008: 2008:723243
16. Lee SS, Pineau T, Drago J, et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 1995; 15: 3012-3022
17. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferatoractivated receptors (PPARs): tissue distribution of PPARalpha, -beta, and -gamma in the adult rat. Endocrinology 1996; 137: 354-366
18. Froment P, Fabre S, Dupont J, et al. Expression and functional role of peroxisome proliferator-activated receptor-gamma in ovarian folliculogenesis in the sheep. Biol Reprod 2003; 69: 1665-1674
19. Jawerbaum A, Capobianco E. Effects of PPAR activation in the placenta and the fetus: implications in maternal diabetes. Placenta 2011; 32 (Suppl. 2): S212-S217
20. Lohrke B, Viergutz T, Shahi SK, et al. Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor gamma in lutein cells. J Endocrinol 1998; 159: 429-439
21. Barak Y, Nelson MC, Ong ES, et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 1999; 4: 585-595
22. Cui Y, Miyoshi K, Claudio E, et al. Loss of the peroxisome proliferation-activated receptor gamma (PPAR gamma) does not affect mammary development and propensity for tumor formation but leads to reduced fertility. J Biol Chem 2002; 277: 17830-17835
23. Lim H, Dey SK. PPAR delta functions as a prostacyclin receptor in blastocyst implantation. Trends Endocrinol Metab 2000; 11: 137-142
24. MacLaren LA, Guzeloglu A, Michel F, Thatcher WW. Peroxisome proliferator-activated receptor (PPAR) expression in cultured bovine endometrial cells and response to omega-3 fatty acid, growth hormone and agonist stimulation in relation to series 2 prostaglandin production. Domest Anim Endocrinol 2006; 30: 155-169
25. Yessoufou A, Hichami A, Besnard P, Moutairou K, Khan NA. Peroxisome proliferator-activated receptor alpha deficiency increases the risk of maternal abortion and neonatal mortality in murine pregnancy with or without diabetes mellitus: modulation of T cell differentiation. Endocrinology 2006; 147: 4410-4418
26. Bogacka I, Bogacki M. The quantitative expression of peroxisome proliferator activated receptors (PPARs) genes in porcine endometrium through the estrous cycle and early pregnancy. J Physiol Pharmacol 2011; 62: 559-565
27. Bogacka I, Bogacki M. Wasielak M. The effect of the embryo presence on the expression of peroxisome proliferator activated receptors (PPARs) genes in the porcine reproductive system during the periimplantation. Acta Vet Hung 2013; 61: 405-415
28. Bogacka I, Bogacki M, Kurzynska A, Chojnowska K. The involvement of peroxisome proliferator activated receptors (PPARs) in prostaglandin F2a production by porcine endometrium. Reprod Biol 2013; 13: 309-316
29. Bogacka I, Bogacki M, Gaglewska M, Kurzynska A, Wasielak M. In vitro effect of peroxisome proliferator activated receptor (PPAR) ligands on prostaglandin E2 synthesis and secretion by porcine endometrium during the estrous cycle and early pregnancy. J Physiol Pharmacol 2013; 64: 47-54
30. Zmijewska A, Franczak A, Kotwica G. Role of interleukin- 1b in the regulation of porcine corpora lutea during the late luteal phase of the cycle and during pregnancy. Acta Vet Hung 2012; 60: 395-407
31. Ottobre JS, Houmard BS, Ottobre AC. Luteal production of steroids and prostaglandins during stimulated early pregnancy in primate: differential regulation of steroids production by chronic gonadotropin. Biol Reprod 1989; 41: 393-400
32. Hotchkiss J, Atkinson LE, Knobil E. Time course of serum estrogen and luteinizing hormone (LH) concentrations during the menstrual cycle of the rhesus monkey. Endocrinology 1971; 89: 177-183
33. Bogacka I, Bogacki M, Boruszewska D, Wasielak M. Expression of peroxisome proliferator activated receptor (PPAR) genes in porcine endometrium exposed in vitro to IL-6 and INFg. Reprod Biol 2012; 12: 157-170
34. Dupont J, Chabrolle C, Rame C, Tosca L, Coyral-Castel S. Role of the peroxisome proliferator-activated receptors, adenosine monophosphate-activated kinase, and adiponectin in the ovary. PPAR Res 2008; 2008: 176275
35. Seto-Young D, Paliou M, Schlosser J, et al. Direct thiazolidinedione action in the human ovary: insulinindependent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production. J Clin Endocrinol Metab 2005; 90: 6099-6105
36. Schoppee PD, Garmey JC, Veldhuis JD. Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. Biol Reprod 2002; 66: 190-198
37. Chen Q, Sun X, Chen J, et al. Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells. Reprod Biol Endocrinol 2009; 7: 147
38. Gasic S, Bodenburg Y, Nagamani M, Green A, Urban RJ. Troglitazone inhibits progesterone production in porcine granulosa cells. Endocrinology 1998; 139: 4962-4966.
39. Gasic S, Nagamani M, Green A, Urban RJ. Troglitazone is a competitive inhibitor of 3beta-hydroxysteroid dehydrogenase enzyme in the ovary. Am J Obstet Gynecol 2001; 184: 575-579
40. Matsuo H, Strauss JF. Peroxisome proliferators and retinoids affect JEG-3 choriocarcinoma cell function. Endocrinology 1994; 135: 1135-1145
41. Gazouli M, Han Z, Papadopoulos V. Identification of a peptide antagonist to the peripheral-type benzodiazepine receptor that inhibits hormone-stimulated Leydig cell steroid formation. J Pharmacol Exp Ther 2002; 303: 627-632
42. Lampen A, Zimnik S, Nau H. Teratogenic phthalate esters and metabolites activate the nuclear receptors PPARs and induce differentiation of F9 cells. Toxicol Appl Pharmacol 2003; 188: 14-23
43. Lovekamp-Swan T, Davis BJ. Mechanisms of phthalate ester toxicity in the female reproductive system. Environ Health Perspect 2003; 111: 139-145
44. Takeuchi S, Iida M, Kobayashi S, Jin K, Matsuda T, Kojima H. Differential effects of phthalate esters on transcriptional activities via human estrogen receptors alpha and beta, and androgen receptor. Toxicology 2005; 210: 223-233
45. Uren-Webster TM, Lewis C, Filby AL, Paull GC, Santos EM. Mechanisms of toxicity of di(2-ethylhexyl) phthalate on the reproductive health of male zebrafish. Aquat Toxicol 2010; 99: 360-369
46. Parillo F, Maranesi M, Brecchia G, Gobbetti A, Boiti C, Zerani M. In vivo chronic and in vitro acute effects of di(2- ethylhexyl) phthalate on pseudopregnant rabbit corpora lutea: possible involvement of peroxisome proliferatoractivated receptor gamma. Biol Reprod 2014; 90: 41
47. Zerani M, Maranesi M, Brecchia G, Gobbetti A, Boiti C, Parillo F. Evidence for a luteotropic role of peroxisome proliferator-activated receptor gamma: expression and in vitro effects on enzymatic and hormonal activities in corpora lutea of pseudopregnant rabbits. Biol Reprod 2013; 88: 62
48. Jalali BM, Kitewska A, Wasielak M, Bodek G, Bogacki M. Effects of seminal plasma and the presence of a conceptus on regulation of lymphocyte-cytokine network in porcine endometrium. Mol Reprod Dev 2014; 81: 270-281.